n an effort to better understand mechanisms of EGFR resistance and to identify new drug candidates, ALCF and ALCMI are partnering with the "
," a group of patients who have come together through the power of social media. This group of individuals now includes over eight hundred people around the globe who are working to advance research on EGFR lung cancer by supporting science and projects with the goal to improve outcomes for people with EGFR positive lung cancer. The ultimate objective is changing EGFR positive lung cancer into a manageable chronic disease.
ALCF and the EGFR Resisters are working together to raise awareness and money for projects that will benefit the EGFR community.
Please show your support today by making a donation below!
(For any check/cash donations, please make sure to indicate which campaign the funds will be credited toward. For example, "EGFR Resisters fundraiser." For wire transfers, please email email@example.com for more information).
Many employers sponsor matching gift programs and will match charitable contributions made by their employees. To find out if your company has a matching gift policy, enter the company name in the search box below.